The German Center for Neurodegenerative Diseases (German: Deutsches Zentrum für Neurodegenerative Erkrankungen, DZNE) aims to develop new preventive and therapeutic approaches for neurodegenerative diseases. To accomplish this the DZNE follows a translational approach. This means that fundamental research is closely related to clinical research, population studies and health care research. In total there are nine sites all over Germany: Berlin, Bonn, Dresden, Göttingen, Magdeburg, Munich, Rostock / Greifswald, Tübingen and Witten. At each site the DZNE works closely with universities, university hospitals and other partners. The DZNE receives 90 percent of its funding from the Federal Ministry of Education and Research and 10 percent from the respective federal states containing DZNE sites.
Some content from Wikipedia, licensed under CC BY-SA
Subscribe to rss feed
The fact that experiences leave their trace in the connectivity of the brain has been known for a while, but a pioneering study by researchers at the German Center for Neurodegenerative Diseases (DZNE) and TUD Dresden University ...
Jul 13, 2023
0
83
Researchers at DZNE and the University Hospital Bonn, together with the Berlin-based company PeakProfiling GmbH, have developed a computer-assisted method that recognizes the severity of speech disturbances resulting from ...
Apr 18, 2023
0
5
Researchers from the DZNE have solved an important puzzle in neurobiology: the wiring and the movement of nerve cells are interwoven, but separately controlled.
Feb 15, 2023
0
92
The protein medin is deposited in the blood vessels of the brains of Alzheimer's patients along with the protein amyloid-β. Researchers from DZNE have discovered this so-called co-aggregation. They have now published their ...
Nov 17, 2022
0
64
Exercise keeps body and mind healthy—but little is known about exactly how and where physical activity affects our brains. "In previous research, the brain was usually considered as a whole," says Fabienne Fox, neuroscientist ...
Aug 3, 2022
0
5
Using a state-of-the-art method, researchers at DZNE and the University of Texas have succeeded for the first time at unraveling the effects of autoimmune antibodies that are directed against the brain in detail at the atomic ...
Jul 8, 2022
0
58
Researchers from DZNE and Ulm University Hospital have identified a protein in the blood that may indicate the degradation of neural connections years before the onset of dementia symptoms. If these findings are confirmed, ...
Jun 27, 2022
0
17
Recovery from severe COVID-19 is characterized by a reduction of certain white blood cells and changes in the molecular regulation of the immune system. This is the conclusion of an international research team coordinated ...
Jun 14, 2022
0
62
Subjective memory disorders in conjunction with conspicuous levels of beta-amyloid proteins in the cerebrospinal fluid are a strong indication of developing Alzheimer's disease. This is the conclusion of a DZNE study involving ...
May 12, 2022
0
26
In the course of Alzheimer's disease, two proteins called amyloid and tau accumulate in the brain. A DZNE study with more than 200 participants now provides insights into the interaction of these pathological phenomena. The ...
Mar 30, 2022
0
18
